- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01978002
Sensory Sensitivity and Urinary Symptoms in the Female Population
Bladder pain and discomfort, as well as urinary urgency and frequency, are bothersome symptoms seen frequently in the general population. Clinical diagnostic terms used to describe these symptoms include interstitial cystitis (IC), bladder pain syndrome (BPS), chronic prostatitis, and overactive bladder (OAB), but there is tremendous overlap between these entities, and the distinction between them is based more on eminence than evidence.
Pain and/or sensory sensitivity has been suspected to play a role in the pathogenesis of both bladder pain and urinary urgency/frequency. However, no previous studies have investigated whether entities such as IC/BPS and OAB might merely represent different points in a continuum of bladder sensory sensitivity. Moreover, we know of no studies that have directly compared sensory sensitivity in the bladder to global (i.e. CNS-mediated) sensory sensitivity.
In the study, a team of investigators with complementary expertise will perform a population-based study assessing bladder and overall sensory sensitivity, in a cohort of women representative of the population with respect to the entire continuum of bladder pain (from none to severe), and symptoms of urgency/frequency. These individuals will undergo urodynamics to measure sensory sensitivity in the bladder, as well as pressure pain and auditory loudness thresholds. The Specific Aims are to demonstrate: 1) sensory sensitivity in the bladder is related to sensory sensitivity elsewhere in the body, suggesting a CNS-driven mechanism, and 2) individuals in the population with greater global sensory sensitivity will display: a) more bladder pain, b) more urgency/frequency, and c) other symptoms of centrally-mediated pain states, such as pain in regions other than the bladder, fatigue, and insomnia.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Group 1 will be women with a clinical diagnosis of IC/BPS or OAB, at least 18 years of age, who have had urodynamic testing performed within the preceding 6 months. All of these subjects will complete the questionnaires, mechanical sensitivity testing, and auditory sensitivity testing
Group 2 will be women recruited from the community sample, at least 18 years of age. All of these subjects will complete the questionnaires, mechanical sensitivity testing, and auditory sensitivity testing. Half of the subjects (n=30) will also undergo urodynamic testing to measure bladder sensitivity.
Description
Inclusion Criteria:
- At least 18 years old
Exclusion Criteria:
- 1) Neurological disease or disorder affecting the bladder; 2) Previous augmentation cystoplasty or cystectomy; 3) Systemic autoimmune disorder (such as Crohn's Disease or Ulcerative Colitis, Lupus, Rheumatoid Arthritis; 4)History of pelvic cancer (colon, bladder, uterus, ovary); 5) Current major psychiatric disorder or other psychiatric or medical issues that would interfere with study participation (e.g. dementia, psychosis, upcoming major surgery, etc); 6) Current pregnancy. These exclusion criteria will be assessed at the time of the initial telephone interview.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1 (Clinic Patients)
Women who have documented urinary status from surveys completed.
|
|
|
Group 2 (Community Sample)
Women who have a clinical diagnosis of IC/BPS or OAB, and who have undergone urodynamic testing within the preceding 6 months as part of their routine clinical care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urodynamics
Time Frame: 1 year
|
Sensation, desire to void, strong desire to void, and maximum cystometric capacity
|
1 year
|
|
Auditory Sensory Sensitivity
Time Frame: 1 year
|
Sensitivity for loudness threshold will be performed using pure tone acoustic stimuli at an octave frequency of 2000 Hz and signal range from 40 to 100 dB
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HUM00054279
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bladder Pain and Discomfort
-
Kaohsiung Medical University Chung-Ho Memorial...Unknown
-
Cairo UniversityCompletedCatheter Related Bladder DiscomfortEgypt
-
Pinar ErgenogluCompleted
-
Jian-jun YangCompletedCatheter Related Bladder DiscomfortChina
-
Ain Shams UniversityCompletedCatheter-related Bladder Discomfort (CRBD)Egypt
-
Seoul National University HospitalCompletedNefopam | Catheter-related Bladder DiscomfortKorea, Republic of
-
Saint Savvas Anticancer HospitalUniversity of ThessalyCompletedPregabalin on Catheter Related Bladder DiscomfortGreece
-
Saint Savvas Anticancer HospitalUniversity of ThessalyWithdrawnPregabalin on Catheter Related Bladder DiscomfortGreece
-
Buddhist Tzu Chi General HospitalNot yet recruitingUrinary Catheter | Catheter-Related Bladder Discomfort
-
Université Catholique de LouvainRecruitingAbdominal Pain/ Discomfort | Intestinal DiscomfortBelgium
Clinical Trials on Pain sensitivity testing
-
Arbor Research Collaborative for HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Washington... and other collaboratorsCompletedLower Urinary Tract SymptomsUnited States
-
University of FloridaNational Center for Complementary and Integrative Health (NCCIH)CompletedLow Back PainUnited States
-
Bispebjerg HospitalRoyal Brompton & Harefield NHS Foundation TrustRecruitingChronic Refractory CoughDenmark
-
University of MinnesotaCompletedDermatitis | Contact Dermatitis | Allergy; DermatitisUnited States
-
Champions OncologyMount Sinai Hospital, CanadaTerminated
-
Soroka University Medical CenterUnknown
-
Eastern Hepatobiliary Surgery HospitalNot yet recruitingHepatocellular Carcinoma ResectableChina
-
Eastern Hepatobiliary Surgery HospitalNot yet recruitingUnresectable Hepatocellular Carcinoma
-
Eastern Hepatobiliary Surgery HospitalNot yet recruitingAdvanced Biliary Tract Cancer(BTC)
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenRecruitingAcute Coronary SyndromesBelgium